Goa Antibiotics And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 34.00 Cr
- Paid Up Capital ₹ 30.96 Cr
- Company Age 44 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.12 Cr
- Satisfied Charges ₹ 11.12 Cr
- Revenue Growth -26.37%
- Profit Growth 28.81%
- Ebitda 17.23%
- Net Worth -59.27%
- Total Assets -6.18%
About Goa Antibiotics And Pharmaceuticals
Goa Antibiotics And Pharmaceuticals Limited (GAAPL) is a leading Public Limited State Government Company incorporated in India on 09 December 1980 and has a history of 44 years and two months. Its registered office is in Goa, Goa, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 34.00 Cr and a paid-up capital of Rs 30.96 Cr.
The company currently has active open charges totaling ₹12.12 Cr. The company has closed loans amounting to ₹11.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Goa Antibiotics And Pharmaceuticals Limited India is Vijaykumar Parapu as CFO. Beji George, Jaideep Mishra, Anitha Thampi, and One other member serve as directors at the Company.
Company Details
- Location
Goa, Goa, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GA1980SGC000412
- Company No.
000412
- Company Classification
Public Limited State Government Company
- Incorporation Date
09 Dec 1980
- Date of AGM
17 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Goa Antibiotics And Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vijaykumar Parapu ![]() | CFO | 20-Nov-2019 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Beji George ![]() | Nominee Director | 27-Mar-2019 | Current |
Jaideep Mishra ![]() | Nominee Director | 24-Oct-2024 | Current |
Anitha Thampi ![]() | Nominee Director | 16-Aug-2023 | Current |
Bhalchandra Angle ![]() | Nominee Director | 01-May-2022 | Current |
Financial Performance of Goa Antibiotics And Pharmaceuticals.
Goa Antibiotics And Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.37% decrease. The company also saw a substantial improvement in profitability, with a 28.81% increase in profit. The company's net worth observed a substantial decline by a decrease of 59.27%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Goa Antibiotics And Pharmaceuticals?
In 2023, Goa Antibiotics And Pharmaceuticals had a public holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹12.12 Cr
₹11.12 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 9.15 Cr
- Others : 2.97 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
22 Dec 2014 | State Bank Of India | ₹9.15 Cr | Open |
02 Feb 1995 | Others | ₹2.97 Cr | Open |
16 Jun 2003 | Central Bank Of India | ₹6.00 M | Satisfied |
08 Nov 1995 | Central Bank Of India | ₹6.70 Cr | Satisfied |
26 Sep 1994 | Central Bank Of India | ₹9.00 M | Satisfied |
How Many Employees Work at Goa Antibiotics And Pharmaceuticals?
Unlock and access historical data on people associated with Goa Antibiotics And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Goa Antibiotics And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goa Antibiotics And Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.